Logo Medical Science Monitor

Call: +1.631.470.9640
Closed: National Holiday

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Functional study of poly(ADP-ribose) glycohydrolase (PARG)

U. Cortes, W. Tong, Z. Herceg, V. Petrilli, E. Jacobson, M. Jacobson, Z. Wang

Med Sci Monit 2003; 9(1): 14- :: ID: 15061


Poly(ADP-ribosyl)ation of proteins is one of the earliest responses to DNA damage in most eukaryotic cells. This posttranslational modification of nuclear proteins is achieved by the enzyme poly(ADP-ribose) polymerase (PARP-1), which synthesizes branched polymers of ADP-ribose (pADPr). Poly(ADP-ribose) polymers are then rapidly catabolized by the degrading enzyme poly(ADP-ribose) glycohydrolase (PARG). Although inhibition or depletion of PARP-1 demonstrates that PARP-1 and poly(ADP-ribosyl)ation play a role in cell proliferation and death, stress response, cell toxicity, DNA repair, recombination, and chromosomal stability, the exact functions of poly(ADP-ribosyl)ation and PARP-1 are largely unknown. This may be due to insufficient knowledge about PARG function, since only a few studies regarding pADPr catabolism have been performed. To better define the functions of PARG and poly(ADP-ribosyl)ation in vivo, we disrupted the PARG gene in ES cells by homologous recombination. Intercrossing of PARG heterozygous (PARG+/D) mice produced a normal mendelian ratio of PARG+/+, PARG+/D and PARGD/D offspring. Interestingly, homozygous PARG knockout mice developed normally, and were healthy and fertile. Expression analysis demonstrated the absence of PARG mRNA in PARGD/D cells and mice, and in the PARG+/D cells, PARG expression was at half of that of wild-type counterparts. These data indicate that PARG is not essential for normal development. Detailed analysis of pADPr metabolism in PARGD/D cells and inflammation response of PARGD/D mice indicate that PARG activity is important for controlling PARP-1 activity in vivo, possibly by regulating its auto-modifications.

Keywords: PARG, Poly(ADP-ribosyl)ation, Gene Targeting

Add Comment 0 Comments

246 0


01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911

In Press

28 May 2023 : Database Analysis  

Scientometric and Visualized Analysis of Intravoxel Incoherent Motion Magnetic Resonance Imaging: 1988-2021

Med Sci Monit In Press; DOI: 10.12659/MSM.938715  

25 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

25 May 2023 : Review article  

A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drug...

Med Sci Monit In Press; DOI: 10.12659/MSM.940635  

25 May 2023 : Clinical Research  

Periapical Lesions and Missed Canals in Endodontically Treated Teeth: A Cone-Beam Computed Tomographic Stud...

Med Sci Monit In Press; DOI: 10.12659/MSM.940533  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750